Abstract:We designed a novel heterocyclic‐substituted 4,5‐dihydropyrazole derivative, MW‐19. MW‐19 exhibited potential antitumor activity, both in vitro and in vivo, and induced HCC‐1806 cell apoptosis. Importantly, blockade of P38 using a pharmacological inhibitor (SB20358) abrogated MW‐19‐induced apoptosis, suggesting that MW‐19 activates the apoptotic P38 MAPK signaling pathway. These findings provide a scientific foundation for the potential development of MW‐19 for treatment of triple‐negative breast cancer. Previous studies have indicated that heterocyclic substituted dihydropyrazole derivatives, particularly MW‐19, potentially exert anticancer activity in vitro; however, the underlying mechanism remains unknown. The present study was designed to investigate the mechanisms underlying MW‐19 activity in triple‐negative breast cancer cells. A sulforhodamine B assay was performed to evaluate cell proliferation inhibition rates, and the antitumor effect of MW‐19 was evaluated in mice with HCC‐1806 xenografts. Apoptosis was analyzed by Hoechst 33342 and annexin V/propidium iodide staining. Expression of pro‐ and antiapoptotic proteins and mRNA were analyzed by western blotting and reverse transcription‐quantitative (RT‐q) PCR, respectively. We found that MW‐19 significantly inhibited HCC‐1806 cell proliferation in a dose‐ and time‐dependent manner, and significantly inhibited MDA‐MB‐231 cell migration. Importantly, oral administration of MW‐19 significantly inhibited HCC‐1806 tumor growth in BALB/c‐nu/nu mice. Moreover, MW‐19 treatment induced marked apoptosis and G2/M arrest in the sensitive cell line, HCC‐1806. RT‐qPCR analysis showed that levels of proapoptotic genes (Bax, caspase‐3, caspase‐7, and Fas) were considerably increased in the MW‐19 group relative to the control group, while those of antiapoptotic factors (Bcl‐2, C‐MYC) were dramatically decreased. Consistently, Bax, caspase‐3, and caspase‐7 were significantly induced after MW‐19 treatment, while levels of phosphorylated (p‐)AKT, p‐PI3K, p‐ERK, and the antiapoptotic protein, Bcl‐2, were clearly diminished, and the P38 MAPK signaling pathway was activated. Furthermore, P38 pharmacological inhibitors abrogated MW‐19‐induced apoptosis. Together, our findings indicate that MW‐19 exerts antitumor effects by targeting PI3K/AKT and ERK/P38 signaling pathways.

Apoptosis Induction of ZBB-006, a Novel Synthetic Diterpenoid, in the Human Hepatocellular Carcinoma Cell Line HepG2 in Vitro and in Vivo.

In vitro and in vivo study of BZG-4000: Anti-tumoral activity of human hepatocellular carcinoma

Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

Antitumor Potential of a Novel Camptothecin Derivative, ZBH-ZM-06

Induction of Apoptosis by Matrine Derivative ZS17 in Human Hepatocellular Carcinoma BEL-7402 and HepG2 Cells Through ROS-JNK-P53 Signalling Pathway Activation

Bakuchiol Induces Apoptosis in Human Hepatocellular Carcinoma Cells HepG2 Via Enhancing Bcl-2/Bax/Cyc-t/Caspase-3 Signaling Pathway

Small Molecular Anticancer Agent Sklb703 Induces Apoptosis in Human Hepatocellular Carcinoma Cells Via the Mitochondrial Apoptotic Pathway in Vitro and Inhibits Tumor Growth in Vivo

Tabersonine Induces the Apoptosis of Human Hepatocellular Carcinoma In vitro and In vivo

Camptothecin-20(s)-O-[N-(3’α,12’α-dihydroxy-24’-carbonyl-5’β-cholan)]-lysine, a Novel Camptothecin Analogue, Induces Apoptosis towards Hepatocellular Carcinoma SMMC-7721 Cells

MW‐19, a dihydropyrazole derivative, induces human triple‐negative breast cancer cell apoptosis by targeting apoptosis‐related pathways

Induction Of Apoptosis By Hac-Y6, A Novel Microtubule Inhibitor, Through Activation Of The Death Receptor 4 Signaling Pathway In Human Hepatocellular Carcinoma Cells

Synthesis and Antitumor Activity of a New 7-Azaindole Derivative

Indole Hydrazide Compound ZJQ-24 Inhibits Angiogenesis and Induces Apoptosis Cell Death Through Abrogation of AKT/mTOR Pathway in Hepatocellular Carcinoma

Anti-Proliferation and Apoptosis Induced by A Novel Intestinal Metabolite of Ginseng Saponin in Human Hepatocellular Carcinoma Cells

A novel camptothecin derivative, ZBH-01, exhibits superior antitumor efficacy than irinotecan by regulating the cell cycle

Camptothecin-20(S)-O-[N-(3 'Alpha,12 'Alpha-Dihydroxy-24 '-Carbonyl-5 'Beta-Cholan)]-Lysine, A Novel Camptothecin Analogue, Induces Apoptosis Towards Hepatocellular Carcinoma Smmc-7721 Cells

N-Benzoyl-12-nitrodehydroabietylamine-7-one, a Novel Dehydroabietylamine Derivative, Induces Apoptosis and Inhibits Proliferation in HepG2 Cells.

Synthesis and Biological Evaluation of a Novel Apogossypolone Derivative

Tanshinone II-A Induced Apoptosis of HepG2: Involvement of P53, Bcl-2 and Bax

Natural Plant Extract Tubeimoside I Promotes Apoptosis-Mediated Cell Death in Cultured Human Hepatoma (hepg2) Cells.